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Background: Dyspnea and exercise intolerance are the symptoms that most affect the quality
of life of children and adolescents with respiratory disorders resulting from cystic fibrosis (CF).
Objective: To evaluate the effect of noninvasive ventilation (NIV) on treadmill 6-min walk dis-
tance and regional chest wall volumes in cystic fibrosis patients.
Method: Crossover clinical trial, randomized, controlled and open with 13 children and adoles-
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Effects of NIV on treadmill 6-min WD and regional chest wall volumes in CF 1461performed a treadmill walking test (TWT) during 6 min, with and without NIV on a BiLEVEL
mode, an interval of 24e48 h between tests. Before and after each test, patients were as-
sessed by spirometry and optoelectronic plethysmography.
Results: Walking distance in TWTwith NIV was significantly higher that without ventilatory sup-
port (mean  sd: 0.41  0.08 vs. 0.39  0.85 km, p Z 0.039). TWT with NIV increase forced
expiratory volume on 1 s (FEV1; p Z 0.036), tidal volume (Vt; p Z 0.005), minute ventilation
(MV; p Z 0.013), pulmonary rib cage volume (Vrcp; p Z 0.011), and decrease the abdominal
volume (Vab; p Z 0.013) after test. There was a significant reduction in oxygen saturation
(p Z 0.018) and permanent increase in respiratory rate after 5 min (p Z 0.021) after the
end test without NIV.
Conclusion: During the walking test on the treadmill, the NIV change thoracoabdominal kine-
matics and lung function in order to optimized ventilation and tissue oxygenation, with
improvement of walk distance. Consequently, NIV is an effective tool to increase functional
capacity in children and adolescents with cystic fibrosis.
ª 2014 Elsevier Ltd. All rights reserved.Introduction
Cystic fibrosis (CF) is a multisystemic disorder in which the
respiratory system is affected in 95% of the cases, and the
primary cause of death in young adults with the disease [1].
Pulmonary impairment is progressive with recurring in-
fectious and inflammatory processes of varying intensity,
involving symptoms such as hypersecretivity and production
of thick tracheobronchial mucus, peripheral airway
obstruction, signs of hyperinflation associated or not to
collapsed lung and atelectasis. These processes culminate
in dyspnea and exercise intolerance, symptomatology that
limits activities of daily living and interferes with the
quality of life of cystic fibrosis patients [1e4].
In addition to respiratory limitations, other factors also
account for reduced functional capacity (FC), including pe-
ripheral muscle weakness, systemic inflammation, oxidative
stress, malnutrition and the inactivity. These factors are a
vicious cycle for deteriorated aerobic conditioning and
increased mortality levels in this population [5e8].
Even though there is still no curative treatment, survival
rates have been increasing due to early diagnosis, multi-
professional management in specialized centers and access
to adequate therapy, mainly in the control of pulmonary
infections, adequate nutrition and as normal a lifestyle as
possible. In this respect, there is a need to investigate
strategies that facilitate physical activities, improving
physical conditioning and exercise tolerance in this popu-
lation [9,10].
Noninvasive ventilation (NIV) has been used to treat
patients with acute and chronic respiratory failure. Studies
with chronic pulmonary patients, including those with
cystic fibrosis, show the benefits of using on alveolar
ventilation, gas exchange, reduced air trapping and pul-
monary hyperinflation. It is also an effective instrument in
improving ventilatory pattern and reducing respiratory
work. However, the immediate effect of this intervention
on daily activities and functional capacity in cystic fibrosis
patients remains unknown and encourages this research
[6,11e20].
Thus, the aim of the present study was to assess the
effect of using NIV during the treadmill walking test on walkdistance, as well as the cardiovascular and thor-
acoabdominal kinematic variables of children and adoles-
cents with CF.
The primary outcome variable is walk distance (WD) in
the TWT and the secondary outcomes are peripheral O2
saturation (SpO2), heart rate (HR), respiratory rate (RR),
score on the Borg dyspnea scale (BDS), forced expiratory
volume in the first second (FEV1), forced vital capacity
(FVC), forced expiratory flow of 25%e75% of FVC (FEF
25e75), minute volume (MV), tidal volume (Vt), pulmonary
rib cage volume (Vrcp), abdominal rib cage volume (Vrca)
abdominal volume (Vab), inspiratory time (Ti), expiratory
time (Te), total ventilatory cycle time (Ttot), duty cycle
(Ti/Ttot) and frequency/tidal volume ratio (RR/Vt).
Method
This is an open randomized controlled crossover clinical
trial. Sample selection was by convenience and patients
were screened at the Pneumology outpatient facility of the
Instituto de Medicina Integral Professor Fernando Figueira
(IMIP) in Recife, Brazil.
The sample was calculated using a software developed
by the Mallinckrodt General Clinical Research Center
(MGH), based on the results of the first 10 volunteers, for a
statistical power of detecting differences between pro-
cedures of 80% and a significance level of 0.05. A sample
size of n Z 13 patients was determined, considering that
the real difference between the walk distance between
procedures with and without NIV is 30 m and the standard
deviation of the differences in variables 34 m.
Inclusion criteria were clinical diagnosis of CF, FEV1
<80% of predicted, age between 7 and 16 years, clinically
stable patients and with no history of hospitalization for
respiratory failure in the last three months.
Exclusion criteria were patients with recent history of
hemoptysis, pneumothorax or evidence of emphysematous
bubbles detected by chest X-ray, Burkholderia cepacia
colonization, the need for more than two physiotherapy
sessions per day, gastroesophageal reflux, orthopedic
trauma or cardiovascular conditions that prevents the
treadmill walk test, and the presence of heart failure.
Figure 1 Representation of methodology. RR: respiratory
rate, HR: heart rate, SpO2: peripheral oxygen saturation, OEP:
optoelectronic plethysmography, min: minutes, TWT: treadmill
walk test, NIV: noninvasive ventilation.
1462 C.A. Lima et al.Moreover, patients with contraindication for NIV, according
to the AARC GUIDELINE (2003) [21], were also excluded.
All patients agreed to take part in the study by giving
their informed consent, in accordance with resolution 196/
96 of the National Health Council.
Technical procedures
Patients were initially assessed for current and past con-
ditions, medication use and anthropometric data (height,
weight and body mass index e BMI). Next, a randomized
plan was compiled using the Web Site Randomization.com,
applying a generator of random-permuted blocks to define
the order in which patients would execute the TWT, with or
without NIV. A minimum and maximum rest period of 24 and
48 h, respectively, was observed between tests.
Before and five minutes after the TWT with and without
NIV, patients were assessed for variations in compartmental
chest wall volume and ventilatory pattern by optoelec-
tronic plethysmography (OEP), which was followed by the
spirometric test. A 30-min of NIV or rest period, at the
moment when the test is done with and without NIV
respectively, was given after the pulmonary function test
before proceeding to the TWT.
The following procedures were involved:
Walk test on the treadmill during 6 min: Prior to the
test, the patient was familiarized with the treadmill (G-
635, Pro Action BH-fitness e Germany) and instructed about
test procedures in accordance with ATS guidelines [22]. The
following parameters were assessed before, immediately
after and in the 5th minute post-test: blood pressure (BP),
respiratory rate (RR), heart rate (HR), Borg’s scale (BS) and
peripheral O2 saturation (SpO2). HR, RR and SpO2 were also
monitored minute by minute during the test, such that a
drop in SpO2 below 87% or rise in RR to more than 75% of
age-predicted maximal HR were used as criteria for inter-
rupting the test [23].
The test initiated with a speed of 2.5 km/h on the
treadmill [24,25]. Every 30 s of the test, the examiner
asked the patient if the speed could be increased, main-
tained or decreased, and patients answered using previ-
ously agreed upon signals. The speed could not exceed
7 km/h and if it was reached, the question would be re-
asked in the next 30 s to determine whether the speed
would be maintained or reduced. After the test, the walk
distance (WD) on the treadmill was recorded.
The TWT performed with NIV followed the same pro-
cedures described above. However, before the test, pa-
tients were submitted to NIV on a BiLEVEL mode
(Synchrony-Respironics, Brazil) for 30 min, as proposed by
Serra et al. [15], with inspiratory airway pressure (IPAP)
level of 12 cmH2O and final expiratory airway pressure
(EPAP) of 6 cmH2O, which can vary by 2 cmH2O more or less
depending on the patient’s comfort, as proposed by Holland
et al. [6] and Granton and Kesten [26]. In the last six mi-
nutes of NIV the patient performed the TWT with the
device.
Optoelectronic plethysmography: The individual was
sitting with 89 retro-reflective sensors at specific thoracic
and abdominal points. Eight cameras were arranged around
the patient for a three-minutes recording of quiet breath-
ing. The three-dimensional co-ordinates markers wererecorded by OEP capture software (BTS Bioengineering,
Italy). From this co-ordinates, the following variables were
calculated by OEP before and five minutes after both tests,
with and without NIV: tidal volume, minute volume, pul-
monary rib cage volume, abdominal rib cage and abdominal
volume of the chest wall (Vt, MV, Vrcp Vrca, Vab), respi-
ratory rate (RR), inspiratory time (Ti), expiratory time (Te),
total ventilatory cycle time (Ttot), duty cycle, which rep-
resents the Ti/Ttot ratio and frequency/tidal volume ratio
(RR/Vt).
Spirometry: Spirometry was conducted using a Micro-
loop MK 8 spirometer (Micro Medical, England) to assess
pulmonary function response, considering a 20-min rest
period between the spirometric test and TWT. Three
reproducible forced maneuvers that met American Thoracic
Society criteria [27] were performed. The highest values
obtained for forced expiratory volume in the first minute
(FEV1), forced vital capacity (FVC), forced vital capacity
Figure 2 Patient recruitment and follow-up flowchart according to CONSORT (Consolidated Standards of Reporting Trials)
statement. CF: cystic fibrosis, NIV: noninvasive ventilation, OEP: optoelectronic plethysmography.
Table 1 Basal clinical characteristics of cystic fibrosis
patients studied.
Patient FEV1 (%) Age (years) BMI (kg/cm
2)
1 50 10 14.6
2 74 9 16
3 79 7 16.2
4 40 10 23.1
5 51 7 13.6
6 35 14 17.4
7 78 10 16.4
8 63 7 13.3
9 79 14 18
10 73 15 15.4
11 80 11 16.6
Effects of NIV on treadmill 6-min WD and regional chest wall volumes in CF 1463between 25 and 75% of FVC (FEF 25e75) were recorded for
analysis.
The flowchart of the methodology is represented on
Fig. 1.
Statistical analysis
Statistical analysis was carried out using SPPS 20.0 statis-
tical software, with a 95% confidence interval for all the
variables.
The ShapiroeWilk test was applied to verify normality
and Levene’s test for homogeneity of variances.
The study variables are presented as mean þ standard
deviation, when distribution is normal, and as median and
interquartile range for non-normal distribution. Inter-group
comparisons were made for characterization variables
using the student’s t-test for independent samples.
The primary outcome, walk distance (WD) in the TWT,
was analyzed by the student’s t-test for independent
samples. Intra- and inter-test comparisons were performed
using the Wilcoxon and ManneWhitney tests, respectively,
for cardiorespiratory (RR, HR and SpO2), and pulmonary
function variables (FEV1, FVC, FEF 25e75) as well as those
resulting from OEP analysis (Vt, MV, Vrcp, Vrca, Vab, Ti, Te,
Ttot, Duty Cycle), measured before and after the TWT.12 63 11 13.9
13 41 15 17.5
FEV1: forced expiratory volume in the first second, kg: kilogram,
cm: centimeters, BMI: body mass index, M: mean, SD: standard
deviation.Results
Of the 38 eligible patients, 21 could not be contacted,
three did not meet inclusion criteria and one refused totake part of the study. Seven of the 13 volunteers, 5 boys
and 2 girls, started the test without NIV and after a rest
period of 24e48 h did the same test with NIV. Six of 13
volunteers, 3 boys and 3 girls did the inverse order (Fig. 2).
The Individual clinical characteristics are exhibited in
Table 1.
All the patients reported regular medical follow-up,
pulmonary impairment (mild, moderate or severe de-
gree), and pancreatic failure with the need for enzyme and
Figure 3 Analysis of walk distance on the TWT with and
without NIV. NIV: noninvasive ventilation, m: meters, CI: con-
fidence interval. *Wilcoxon test.
1464 C.A. Lima et al.vitamin supplementation. Seven of the 13 patients had
normal BMI for age, according to the World Health Organi-
zation (2006) [28], while the rest were classified as low
weight. Furthermore, except for one individual, all the
patients used dornase alfa.
The walk distance was greater on the TWTwith NIV, with
a mean of 415.38  77.52 m compared to
386.92  84.89 m for the same test without NIV (pZ 0.039;
Fig. 3).
Fig. 4 shows the RR, counted by ventilator pattern, HR
and SpO2 before, immediately after and 5 min after each
test, separately and between them. Likewise, SBP, DBP and
Borg’s dyspnea scale modified (BS) were also evaluated.
The BS is described on Fig. 5.
With respect to the responses of cardiorespiratory vari-
ables to the TWT, there was no significant difference be-
tween the groups immediately after the tests with and
without NIV. Both groups increased HR and RR, due to the
rise in cardiorespiratory demand caused by physical exer-
cise. However, only in those who underwent the TWT
without NIV was there significant desaturation (pZ 0.018),
with permanent increase in RR after 5 min (pZ 0.001). It is
important to note that at no time the patients reach age-Figure 4 Analysis of intra- and inter-test RR, HR and SpO2.
tilation.*Wilcoxon test.predicted HRmax. Moreover, there was no variation in
intra- and inter-test SBP and DBP.
There was no inter-test difference in perceived exer-
tion, as quantified by Borg’s scale. An increase in median
and interquartile range (IR) scores occurred in both groups,
immediately after the test. The post-test without NIV
exhibited an increase from 0 (0e0.75) to 3 (2.5e7.5) points
and in the post-test with NIV from 0 (0e0.5) to 4 (2e6)
points, both with p < 0.001. After 5 min, median (IR) of the
BS returned to 0 (0e1.5) and 1 (0e2) points on the TWT
without and with NIV, respectively, significantly higher than
the initial value only on the TWT with NIV (p Z 0.033). No
significant difference was found between the tests.
The spirometric variables, before and after each test, is
described in Table 2. There was an increase in FEV1 post-
test only when exercise was performed with NIV
(p Z 0.036). There were no inter-group differences.
Fig. 6 and Table 3 show the rib cage volumes variation,
as well as variables that reflect ventilatory pattern (MV, RR,
Ti, Te, Ttot, Duty Cycle and RR/Vt). The total volume of the
rib cage increased after exercise, but the rise was only
significant when exercise was associated to NIV. Moreover,
when the TWT is associated to NIV, Vt increased
(p Z 0.005), causing an alteration in thoracoabdominal
kinematics, raising Vrcp and decreasing Vab (pZ 0.011 and
pZ 0.013) respectively. There was no significant change in
final values between procedures.
The TWT with NIV increased MV when compared to
baseline (p Z 0.013), increase Vt (p Z 0.005), but did not
influence the final values of RR, RR/Vt and ventilatory cycle
times. There was no significant change in the ventilatory
pattern in the post-test without NIV.
Discussion
Earlier studies in patients with CF showed NIV benefits in
recruiting collapsed alveolar units, improving alveolar
ventilation and oxygenation, reducing respiratory work and
air trapping [15,17,29e31]. The present study shows that
these benefits remain in a situation of cardiorespiratory
overload, such as physical exercise. The previous and
associated use of NIV prevented exercise-induced desatu-
ration and reduced the time required to restore ventilatory
supply-demand equilibrium after the stress test, since only
on the TWT without NIV did RR remain elevated in theSpO2: peripheral oxygen saturation, NIV: noninvasive ven-
Figure 5 Borg’s dyspnea scale modified.
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improvement in pulmonary function, observed by the in-
crease in FEV1 post-test, makes NIV an instrument that
restores or strengthens the capacity of patients with CF to
engage in physical activity.
In addition to enhancing pulmonary function and pe-
ripheral oxygenation, our findings show that the use of NIV
during the TWT caused an increase in post-test Vt and MV in
children and adolescents with CF.
This assessment of changes in pulmonary volumes was
performed using OEP. In addition to evaluate the changes
in the distribution of rib cage volume by compartments,
this instrument is capable of evaluating which type of
kinematic alteration is responsible for variations in Vt
[32].
The heterogeneity of pleural pressure on the costal
surface and the different arrangement of inspiratory and
expiratory musculature in the rib cage cause different be-
haviors on pulmonary and thoracic mechanics in certain
situations. It is therefore important to separately assess theTable 2 Analysis intra- and inter-test of spirometric variables,
TWT without NIV (n Z 13)
Median (IR) Intra-tes
p-valuea
FEV1 (ml)
(%)
Before 1.03 (0.83e1.7) e
After 1.01 (0.85e1.68) 0.906
Before 63 (40.5e76.5) e
After 61 (40.5e76) 0.608
FVC (ml)
(%)
Before 1.75 (1.31e2.31) e
After 1.74 (1.23e2.24) 0.834
Before 78 (64.5e94) e
After 74 (59.5e94) 0.844
FEF 25e75
(L/s)
(%)
Before 0.74 (0.43e1.87) e
After 0.67 (0.47e1.83) 0.834
Before 38 (18e85) e
After 36 (23.5e90) 0.583
TWT: treadmill walk test, NIV: noninvasive ventilation, FEV1: forced
FEF 25e75: forced expiratory flow between 25 and 75% of FVC. IR: in
a Wilcoxon test.
b ManneWhitney test.mechanics of the rib cage in relation to the lungs (RCp) and
against the diaphragm (RCd) and abdomen (RCa) [33].
We observed that exercise with NIV altered thor-
acoabdominal kinematics, significantly increasing Vrcp and
reducing Vab. The greater expansion of the pulmonary rib
cage in detriment to the reduction of Vab demonstrates
that there was a difference in pressures acting on the rib
cage. Cala et al. [34] reports that the increase in Vt fol-
lowed by this thoracoabdominal pattern occurs due to
greater recruitment of inspiratory than expiratory reserve
volume [35,36,37]. Thus, the mixed pattern of restrictive
and obstructive pulmonary impairment in CF was modified
by the use of NIV such that Vt increased as a result of
greater rib cage mobilization and a rise in its volume-
generating capacity.
MV grew after exercise associated to the use of NIV due
to increased Vt and not RR. So, instead of no statistically
difference on RR/Vt ratio, the use of NIV tends to minimize
the rapid and shallow breathing pattern after the test,
suggesting an improvement in alveolar ventilation [38].
There was no difference in ventilatory cycle variables
as measured by OEP. However, the basal duty cycle of
cystic fibrosis patients is above normal values (between 30
and 40%). Duty cycle is the Ti/Ttot ratio of the ventilatory
cycle and reflects the part of the effective diaphragm
contraction cycle. High values, such as those observed in
our sample, show a pattern of tachypnea, a decline in
exhalatory time and greater disposition to a rise in res-
piratory work and respiratory muscle fatigue in situations
of increased cardiorespiratory demand, such as physical
exercise [39]. Moreover, mean duty cycle values were
higher after exercise without NIV when compared to post-
exercise values with NIV, but without statistical
significance.
The present study shows that patients submitted to the
TWT with NIV obtained better results, underscoring the
longer walk distance and consequent enhanced functional
capacity.with and without NIV.
TWT with NIV (n Z 13)
t Median (IR) Intra-test
p-valuea
Inter-test
p-valueb
1.14 (0.96e1.61) e 0.724
1.18 (1e1.84) 0.036 0.362
54 (44e82) e 0.762
67 (50e82) 0.289 0.579
1.84 (1.4e1.91) e 1.00
1.67 (1.35e2.4) 0.208 0.88
76 (62.5e98) e 1.00
83 (60.5e102.5) 0.074 0.579
0.8 (0.65e2.05) e 0.418
1.15 (0.64e2.19) 0.75 0.243
53 (31e99.5) e 0.511
58 (34e103.5) 0.197 0.204
expiratory volume in the first second, FVC: forced vital capacity,
terquartile range, ml: milliliters, L: liters, s: seconds.
Figure 6 Analysis of variation in rib cage volume by OEP. NIV: noninvasive ventilation, Vrcp: pulmonary rib cage volume, Vrca:
abdominal rib cage volume, Vab: abdominal volume. *Wilcoxon test.
1466 C.A. Lima et al.The multisystem etiology of CF and the complex phys-
iopathology of pulmonary impairment highlight the impor-
tance of assessing the impact of NIV not only in pulmonary
function, but also in functional capacity. The ability to
engage in physical exercise, when objectively determined,
is a more effective marker of the prognosis and quality of
life in this population, which can be improved with a
rehabilitation program even when the pulmonary impair-
ment of the disease cannot be altered [29,30].
There was a significant increase in walk distance on the
TWT when it was performed with ventilatory assistance.
Our findings suggest that improved peripheral oxygenation
and pulmonary function, caused by the use of NIV at two
pressure levels, reduced the overload imposed on ventila-
tory muscles and increases the functional capacity of pa-
tients with CF. Accordingly, the use of NIV proved to be a
necessary means of ventilatory support to supply theTable 3 Analysis of volumes and ventilatory pattern by intra- a
TWT without NIV (n Z 13)
Median (IR) Intra-te
p-value
Vt (L) Before 0.31 (0.22e0.42) e
After 0.33 (0.3e0.37) 0.162
MV (L) Before 7.354 (4.844e9.575) e
After 8.185 (6.667e8.945) 0.064
RR (ipm) Before 23.8 (19.4e31.8) e
After 25.3 (20.2e28.6) 0.638
Ttot (s) Before 2.5 (1.9e3.1) e
After 2.4 (2.1e3) 0.937
Ti (s) Before 1.06 (0.85e1.47) e
After 0.99 (0.85e1.39) 0.753
Te (s) Before 1.47 (1.05e1.95) e
After 1.38 (1.2e1.69) 0.861
Duty
cycle (%)
Before 43.1 (40.2e47.2) e
After 43.3 (38.-45.2) 0.463
RR/Vt
(ipm/L)
Before 80.0 (44.4e101.4) e
After 75.2 (57.8e98.5) 0.552
TWT: treadmill walk test, NIV: noninvasive ventilation, Vt: tidal volum
inspiratory time, Te: expiratory time, IR: interquartile range, L: liter
a Wilcoxon test.
b ManneWhitney test.increased ventilatory demand and increase the functional
capacity of this group of patients [12,14].
Similar results were found in patients with cardiopathies
and chronic obstructive pulmonary disease, but are new in
patients with cystic fibrosis in any age group [40,41].
A limiting factor of our study was the inability to assess
the impact of NIV on ventilatory pattern, as measured by
OEP during the test. This is due to the positive thoracic
pressure exerted by NIV in cardiopulmonary interaction,
modifying hemodynamics and blood volume in the chest
and abdomen of individuals. These alterations in blood
volume likely interfere in the assessment of total and rib
cage compartment volumes [42].
Furthermore, Borg’s scale was difficult for the children
to understand, limiting the validity of our results with
respect to this variable. The young age and poor schooling
level of the population, as well as the low socioeconomicnd inter-test OEP.
TWT with NIV (n Z 13)
st Median (IR) Intra-test
p-valuea
Inter-test
p-valueb
0.33 (0.23e0.39) e 1.00
0.36 (0.29e0.44) 0.005 0.418
7.282 (5.712e9.465) e 0.92
8.390 (6.322e9.509) 0.013 0.84
23.5 (18.3e29.5) e 0.84
21.7 (19.3e27.3) 0.463 0.418
2.6 (2e3.5) e 0.801
2.8 (2.2e3.1) 0.875 0.479
1.14 (0.92e1.42) e 0.687
1.1 (0.93e1.23) 0.552 0.579
1.6 (1.18e1.99) e 0.762
1.7 (1.31e1.98) 0.382 0.39
41.8 (39.2e46.5) e 0.579
39.8 (37.9e44.7) 0.116 0.479
73.5 (54.0e101.3) e 0.272
61.7 (42.4e82.6) 0.087 0.158
e, MV: minute volume, RR: respiratory rate, Ttot: total time, Ti:
s, s: seconds ipm: incursions per minute.
Effects of NIV on treadmill 6-min WD and regional chest wall volumes in CF 1467status of the sample may have been the cause of this lim-
itation. Hook et al. [43] showed that low economic status
has an influence in a wide range of situations, including
cognitive skills, school performance, executive ability and
even physical and mental health.
Conclusion
The pulmonary impairment in cystic fibrosis patients can
increase the ventilatory demand even in performing their
activities of daily living. Dyspnea being an important
limiting factor in their functionality and quality of life.
Given the impossibility of altering the severity of pul-
monary impairment, the present study proved that the
immediate use of NIV in the BiLEVEL mode improves pul-
monary function, respiratory muscle strength, peripheral
oxygenation, as well as providing the ventilatory support
required to increase the functional capacity of children and
adolescents with CF.
Studies that assess the impact of NIV associated to a
pulmonary rehabilitation program on long-term functional
capacity, health gains, physical conditioning and function-
ality scale should be encouraged.
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